Status:
COMPLETED
Identification of Characteristics Associated With Symptom Remission in Autism
Lead Sponsor:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorders
Autism
Eligibility:
All Genders
7-17 years
Brief Summary
Autism is defined as a lifelong pervasive developmental disability, as such, symptom recovery is considered rare. Reports by Lovaas and McEachin, Smith \& Lovaas and more recently by Cohen, Amerine-Di...
Detailed Description
Autism is defined as a lifelong pervasive developmental disability, as such, symptom recovery is considered rare. Reports by Lovaas and McEachin, Smith \& Lovaas and more recently by Cohen, Amerine-Di...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- STUDY SUBJECTS:
- Remitted Autism (REM-AUT) Group:
- Diagnosis of autism prior to symptom improvement
- valid administration of ADI and/or ADOS with accompanying interpretive report yielding an autism diagnosis
- OR
- clinical/developmental evaluation including a detailed review of the child s history and direct observation of current behavioral functioning resulting in a documented diagnosis of autism by a child developmental specialist experienced with autism spectrum disorders such as a developmental pediatrician, developmental psychologist, child clinical psychologist, or a child psychiatrist
- measure of cognitive ability from within 1 year of initial autism diagnosis
- objective measure indicative of prominent autism symptoms using a recognized and standardized assessment of autism symptoms such as the Social Responsiveness Scale (SRS), Childhood Autism Rating Scale (CARS), or the Modified Checklist for Autism in Toddlers (MCHAT) or video tapes of assessments
- initial diagnosis of autism prior to age 6
- AND
- Medical, educational, treatment record review by PDN branch clinicians to confirm diagnostic impressions including a detailed description of child s behaviors that support an autism diagnosis
- The final decision for meeting diagnostic and treatment history inclusion criteria is based on PDN branch staff review of the case
- Treatment history: all participants must have received adequate treatment intervention for their autism symptoms. Participant medical and treatment records will be carefully reviewed to ascertain their treatment history
- Current functioning:
- a. Parent report and report of at least one professional that child is no longer autistic
- At screening visit (after meeting initial eligibility), will not meet criteria for autism
- Must not meet criteria for autism per overall clinical impression based on information collected from administration of the ADOS, current ADI-R symptoms, and other clinical observations made the assessment.
- Teacher/informant report of autism symptoms (such as results from the SRS) not indicative of autism diagnosis
- Minimum improvement of symptoms required from group assignment: approximately 2 point CGI severity of illness change (or equivalent) based on PDN impression of change in illness severity from initial diagnosis (estimated based on review of past medical records) and current functioning
- OR
- Current assessment of functional impairment due to autism symptoms using a standardized assessment measure such as the Developmental Disability-Children s Global Assessment Scale will reflect adequate functioning in all areas and/or a clinically significant improvement in functioning, consistent with common psychiatric treatment definitions for treatment response
- Able to participate in study procedures.
- AUTISM Group:
- Diagnosis of autism following the same criteria as described above
- Treatment history: all study participants must have received adequate treatment intervention. Treatment history will be matched to treatment provided to children in the REM-AUT group.
- Screening visit (after meeting initial eligibility): will meet criteria for autistic disorder using the same diagnostic process described for the REM-AUT group above
- Matched to REM-AUT group on IQ, age of diagnosis, and treatment history. IQ matching between the AUT and REM-AUT groups will be based on pretreatment estimates of cognitive level obtained from the medical record review.
- Able to participate in study procedures.
- TD Group:
- IQ matched to a sub-sample of children in the REM-AUT group with normal range intellectual functioning. IQ matching between the TD and REM-AUT groups will be based on current intellectual functioning at the time of study participation.
- Able to participate in study procedures.
- EXCLUSION CRITERIA:
- All groups: May not be pregnant or have a known genetic disorder, mitochondrial disease, history of birth trauma, or current uncontrolled seizures
- TD Group:
- Current diagnosis or significant history of pervasive developmental disorder, language delay or disorder (except articulation), attention or learning issues, or major psychiatric condition.
- Prematurity at birth less than 36 weeks gestation); or birth weight significantly below normal for gestational age (SGA- small for gestational age).
- PARENTS OF ALL STUDY PARTICIPANTS:
- As noted parents of all study groups will provide DNA, plasma, and serum samples.
Exclusion
Key Trial Info
Start Date :
June 25 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 9 2012
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT00938054
Start Date
June 25 2009
End Date
October 9 2012
Last Update
October 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892